John P. Schmid - 09 Aug 2024 Form 4 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Role
Director
Signature
/s/ Beth Hecht, as Attorney-in-Fact
Issuer symbol
XERS
Transactions as of
09 Aug 2024
Net transactions value
+$10,134
Form type
4
Filing time
12 Aug 2024, 18:28:50 UTC
Previous filing
18 Jun 2024
Next filing
13 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XERS Common Stock Purchase $10,134 +4,285 +26% $2.36 20,685 09 Aug 2024 By: The Schmid Family Trust dated August 15, 2017 F1
holding XERS Common Stock 113,159 09 Aug 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.